Vyndaqel-H-C-PSUSA-00002842-202205: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Vyndaqel-H-C-PSUSA-00002842-202205: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Zaawansowana formuła farmaceutyczna do celowanego działania terapeutycznego.
Dawkowanie
Vyndaqel-H-C-PSUSA-00002842-202205: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Moc
Vyndaqel-H-C-PSUSA-00002842-202205: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Wielkość opakowania
Vyndaqel-H-C-PSUSA-00002842-202205: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Postać
Vyndaqel-H-C-PSUSA-00002842-202205: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Źródło
European Medicines Agency
